California

Latest California Healthline Stories

LA’s First Heat Officer Says Helping Vulnerable Communities Is Key to Achieving Climate Goals

Los Angeles taps Marta Segura, director of the city’s climate emergency mobilization office, as its first heat officer. Segura, the first Hispanic person to hold such a position in the country, will work across city departments on an early warning system while developing cooling strategies.

Three-Year Abortion Trends Vary Dramatically by State

About 930,000 abortions occurred in the U.S. in 2020, an 8% increase from 2017. But that nationwide figure belies dramatic variation among states — disparities expected to magnify in the wake of the Supreme Court’s decision to strike down Roe v. Wade.

Medi-Cal Will Cover Doulas at More Than Twice California’s Initial Proposed Rate

Under a budget passed by California lawmakers, the state will pay nonmedical workers who assist in pregnancy and labor up to $1,154 per birth through Medi-Cal, which is up significantly from Gov. Gavin Newsom’s initial offer of $450. Though it’s more than what most other states pay, many doulas say it falls short of the $3,600 they sought.

At a Bay Area ‘Test-to-Treat’ Site, Few Takers for Free Antivirals

In carrying out the federal covid-19 “test-to-treat” initiative, California is targeting the uninsured by outfitting 138 testing sites with screenings for free antiviral drugs. But as of mid-June, fewer than 800 people had been prescribed the medicines. And two-thirds of those undergoing screenings are insured.

Lawmaker Takes on Insurance Companies and Gets Personal About His Health

State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.

California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can it Succeed?

Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.